| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 53.598 | 57.117 | 61.503 | 72.682 | 81.555 | 96.323 | 101.318 | 115.832 | 148.472 | 155.639 |
| Total Income - EUR | 53.601 | 57.120 | 61.507 | 72.703 | 81.601 | 96.336 | 101.339 | 115.899 | 158.932 | 159.684 |
| Total Expenses - EUR | 44.165 | 43.154 | 44.030 | 46.491 | 56.438 | 72.983 | 75.444 | 91.950 | 109.404 | 122.441 |
| Gross Profit/Loss - EUR | 9.436 | 13.966 | 17.477 | 26.212 | 25.163 | 23.353 | 25.896 | 23.949 | 49.529 | 37.242 |
| Net Profit/Loss - EUR | 7.828 | 13.394 | 16.861 | 25.484 | 24.460 | 22.582 | 25.181 | 23.184 | 48.348 | 32.548 |
| Employees | 7 | 5 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 4 |
Check the financial reports for the company - Harmomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.384 | 3.337 | 1.945 | 900 | 10.139 | 10.810 | 9.691 | 7.019 | 6.882 | 16.559 |
| Current Assets | 15.476 | 12.429 | 16.897 | 37.898 | 47.389 | 66.162 | 88.407 | 111.935 | 47.040 | 26.513 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 86 | 11 | 0 | 0 | 0 |
| Receivables | 10.478 | 6.995 | 10.324 | 26.954 | 7.122 | 10.609 | 8.804 | 10.032 | 23.765 | 3.731 |
| Cash | 4.998 | 5.434 | 6.573 | 10.944 | 40.267 | 55.466 | 79.592 | 101.903 | 23.275 | 22.782 |
| Shareholders Funds | 17.880 | 13.448 | 16.914 | 36.995 | 55.218 | 70.943 | 94.551 | 111.944 | 48.396 | 32.596 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.160 | 2.318 | 1.928 | 1.911 | 2.382 | 6.065 | 3.582 | 7.027 | 5.526 | 10.476 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Harmomed Srl